These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 32808928)

  • 1. Binding mechanism of the matrix domain of HIV-1 gag on lipid membranes.
    Monje-Galvan V; Voth GA
    Elife; 2020 Aug; 9():. PubMed ID: 32808928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationships between MA-RNA Binding in Cells and Suppression of HIV-1 Gag Mislocalization to Intracellular Membranes.
    Thornhill D; Olety B; Ono A
    J Virol; 2019 Dec; 93(23):. PubMed ID: 31511376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Membrane Binding of HIV-1 Matrix Protein: Dependence on Bilayer Composition and Protein Lipidation.
    Barros M; Heinrich F; Datta SAK; Rein A; Karageorgos I; Nanda H; Lösche M
    J Virol; 2016 May; 90(9):4544-4555. PubMed ID: 26912608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cooperative Membrane Binding of HIV-1 Matrix Proteins.
    Banerjee P; Monje-Galvan V; Voth GA
    J Phys Chem B; 2024 Mar; 128(11):2595-2606. PubMed ID: 38477117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opposing mechanisms involving RNA and lipids regulate HIV-1 Gag membrane binding through the highly basic region of the matrix domain.
    Chukkapalli V; Oh SJ; Ono A
    Proc Natl Acad Sci U S A; 2010 Jan; 107(4):1600-5. PubMed ID: 20080620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural and Molecular Determinants of Membrane Binding by the HIV-1 Matrix Protein.
    Mercredi PY; Bucca N; Loeliger B; Gaines CR; Mehta M; Bhargava P; Tedbury PR; Charlier L; Floquet N; Muriaux D; Favard C; Sanders CR; Freed EO; Marchant J; Summers MF
    J Mol Biol; 2016 Apr; 428(8):1637-55. PubMed ID: 26992353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular determinants that regulate plasma membrane association of HIV-1 Gag.
    Chukkapalli V; Ono A
    J Mol Biol; 2011 Jul; 410(4):512-24. PubMed ID: 21762797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-1 Matrix Protein Interactions with tRNA: Implications for Membrane Targeting.
    Gaines CR; Tkacik E; Rivera-Oven A; Somani P; Achimovich A; Alabi T; Zhu A; Getachew N; Yang AL; McDonough M; Hawkins T; Spadaro Z; Summers MF
    J Mol Biol; 2018 Jul; 430(14):2113-2127. PubMed ID: 29752967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trio engagement via plasma membrane phospholipids and the myristoyl moiety governs HIV-1 matrix binding to bilayers.
    Vlach J; Saad JS
    Proc Natl Acad Sci U S A; 2013 Feb; 110(9):3525-30. PubMed ID: 23401539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myristate exposure in the human immunodeficiency virus type 1 matrix protein is modulated by pH.
    Fledderman EL; Fujii K; Ghanam RH; Waki K; Prevelige PE; Freed EO; Saad JS
    Biochemistry; 2010 Nov; 49(44):9551-62. PubMed ID: 20886905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of PI(4,5)P2 Enrichment in HIV-1 Viral Membranes.
    Wen Y; Feigenson GW; Vogt VM; Dick RA
    J Mol Biol; 2020 Sep; 432(19):5343-5364. PubMed ID: 32739462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Membrane-induced alterations in HIV-1 Gag and matrix protein-protein interactions.
    Scarlata S; Ehrlich LS; Carter CA
    J Mol Biol; 1998 Mar; 277(2):161-9. PubMed ID: 9514761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between HIV-1 Gag Multimerization and Membrane Binding.
    Sumner C; Ono A
    Viruses; 2022 Mar; 14(3):. PubMed ID: 35337029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural Insights into the Mechanism of Human T-cell Leukemia Virus Type 1 Gag Targeting to the Plasma Membrane for Assembly.
    Herrmann D; Zhou LW; Hanson HM; Willkomm NA; Mansky LM; Saad JS
    J Mol Biol; 2021 Sep; 433(19):167161. PubMed ID: 34298060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-1 Gag specificity for PIP
    Socas LBP; Ambroggio EE
    Biochim Biophys Acta Biomembr; 2023 Jun; 1865(5):184157. PubMed ID: 37028700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles played by acidic lipids in HIV-1 Gag membrane binding.
    Olety B; Ono A
    Virus Res; 2014 Nov; 193():108-15. PubMed ID: 24998886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphatidylinositol-(4,5)-Bisphosphate Acyl Chains Differentiate Membrane Binding of HIV-1 Gag from That of the Phospholipase Cδ1 Pleckstrin Homology Domain.
    Olety B; Veatch SL; Ono A
    J Virol; 2015 Aug; 89(15):7861-73. PubMed ID: 25995263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the Gag matrix domain in targeting human immunodeficiency virus type 1 assembly.
    Ono A; Orenstein JM; Freed EO
    J Virol; 2000 Mar; 74(6):2855-66. PubMed ID: 10684302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of myristoylation, liposome surface charge and nucleic acid interaction in the partition properties of HIV-1 Gag-N-terminal peptides to membranes.
    Pérez Socas LB; Ambroggio EE
    Biochim Biophys Acta Biomembr; 2020 Nov; 1862(11):183421. PubMed ID: 32710855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-1 Matrix Trimerization-Impaired Mutants Are Rescued by Matrix Substitutions That Enhance Envelope Glycoprotein Incorporation.
    Tedbury PR; Novikova M; Alfadhli A; Hikichi Y; Kagiampakis I; KewalRamani VN; Barklis E; Freed EO
    J Virol; 2019 Dec; 94(1):. PubMed ID: 31619553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.